Nilay V. Patel

Student
Department of Pharmaceutical Economics and Policy, School of Pharmacy, University of Southern California

Papers:

18 Pregabalin (Lyrica®) is cost-effective over Gabapentin (Neurontin®) as a First-Line Treatment for Neuropathic Pain (NeP) Management after Spinal Cord Injury (SCI)

American Society of Health Economists (ASHEcon)

1100 Vermont Avenue NW Suite 650

Washington, DC 20005

P: (202) 737 6608

F: (202) 496 0134

Copyright © 2017 ASHEcon - All rights reserved.